CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (USD $) In Millions, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME
Product revenue	$ 1,611.4	$ 1,556.5	$ 1,445.6
Service revenue	219.3	210.0	194.8
Other revenue	8.7	24.9	11.3
Total revenue	1,839.4	1,791.4	1,651.7
Cost of product revenue	891.7	837.2	792.5
Cost of service revenue	142.5	124.8	106.7
Total cost of revenue	1,034.2	962.0	899.2
Gross profit	805.2	829.4	752.5
Operating expenses:
Selling, general and administrative	437.9	440.4	406.6
Research and development	190.5	195.3	177.2
Impairment of assets		23.8
Write-off of deferred offering costs			3.4
Other charges, net	28.6	13.9	9.7
Total operating expenses	657.0	673.4	596.9
Operating income	148.2	156.0	155.6
Interest and other income (expense), net	(23.6)	(17.7)	(10.1)
Income before income taxes and noncontrolling interest in consolidated subsidiaries	124.6	138.3	145.5
Income tax provision	42.8	60.1	51.5
Consolidated net income	81.8	78.2	94.0
Net income attributable to noncontrolling interest in consolidated subsidiaries	1.7	0.7	1.7
Net income attributable to Bruker Corporation	80.1	77.5	92.3
Net income per common share attributable to Bruker Corporation shareholders:
Basic (in dollars per share)	$ 0.48	$ 0.47	$ 0.56
Diluted (in dollars per share)	$ 0.48	$ 0.46	$ 0.55
Weighted average common shares outstanding:
Basic (in shares)	166.5	166.0	165.4
Diluted (in shares)	168.5	167.4	166.9
Consolidated net income	81.8	78.2	94.0
Foreign currency translation adjustments	27.3	8.8	(14.7)
Changes in hedging instruments		1.1	1.9
Pension liability adjustments (net of tax of $4.6 million, $3.7 million and $0.6 million, respectively)	17.3	(15.0)	2.9
Net comprehensive income	126.4	73.1	84.1
Less: Comprehensive income attributable to noncontrolling interests	1.7	0.3	1.7
Comprehensive income attributable to Bruker Corporation	$ 124.7	$ 72.8	$ 82.4